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Abstract 
Background: The global malaria decline has stalled and only a few countries are pushing towards pre-elimination. 
The aim of the malaria elimination phase is interruption of local transmission of a specified malaria parasite in a 
defined geographical area. New and improved screening tools and strategies are required for detection and manage-
ment of very low-density parasitaemia in the field. The objective of this study was to synthesize evidence on the diag-
nostic accuracy of loop-mediated isothermal amplification (LAMP) test for the detection of malaria parasites among 
people living in endemic areas.
Methods: This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis for 
Diagnostic Test Accuracy (PRISMA-DTA) guideline. Relevant studies in the health-related electronic databases were 
searched. According to the criteria set for this study, eligible studies were identified. The quality of included stud-
ies was evaluated with the use of a quality assessment checklist. A summary performance estimates such as pooled 
sensitivity and specificity were stratified by type of LAMP. Bivariate model for data analyses was applied. Summary 
receiver operating characteristics plots were created to display the results of individual studies in a receiver operat-
ing characteristics space. Meta-regression analysis was performed to investigate the sources of heterogeneity among 
individual studies.
Results: Twenty-seven studies across 17 endemic countries were identified. The vast majority of studies were with 
unclear risk of bias in the selection of index test. Overall, the pooled test performances were high for Pan LAMP (sensi-
tivity: 0.95, 95% CI 0.91 to 0.97; specificity: 0.98, 95% CI 0.95 to 0.99), Plasmodium falciparum (Pf) LAMP (sensitivity: 0.96, 
95% CI 0.94 to 0.98; specificity: 0.99, 95% CI 0.96 to 1.00) or for Plasmodium vivax (Pv) LAMP from 6 studies (sensitivity: 
0.98, 95% CI 0.92 to 0.99; specificity: 0.99, 95% CI 0.72 to 1.00). The area under the curve for Pan LAMP (0.99, 95% CI 
0.98–1.00), Pf LAMP (0.99, 95% CI 0.97–0.99) and Pv LAMP was (1.00, 95% CI 0.98–1.00) indicated that the diagnostic 
performance of these tests were within the excellent accuracy range. Meta-regression analysis showed that sample 
size had the greatest impact on test performance, among other factors.
Conclusions: The current findings suggest that LAMP-based assays are appropriate for detecting low-level malaria 
parasite infections in the field and would become valuable tools for malaria control and elimination programmes. 
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Background
The global malaria decline has stalled and only a few 
countries are pushing towards pre-elimination [1]. The 
aim of the malaria elimination phase is interruption of 
local transmission of a specified malaria parasite in a 
defined geographical area [2]. Although there were an 
estimated 20 million fewer malaria cases in 2017 than 
in 2010, the World Malaria Report 2018 highlights that 
no significant progress in reducing global malaria cases 
was made in the period 2015–2017 [1]. For instance, the 
ten highest malaria burden African countries had an esti-
mated 3.5 million more malaria cases in 2017 compared 
with the previous year [1]. In order to reduce and even-
tually eliminate the parasite reservoir, early detection of 
infected individuals and effective treatment with gameto-
cidal drugs are important, whilst mosquito activities are 
minimal [1, 2].
To meet the target of malaria elimination, surveil-
lance for submicroscopic infections is crucially impor-
tant. Strategies to interrupt malaria transmission include 
prompt identification and treatment of asymptomatic 
infections. The majority of asymptomatic had low para-
site densities, undetectable by microscopy or RDT, but 
can currently be identified reliably by PCR. However, 
PCR is time and resource intensive, and it is not a viable 
method in field operations. New and improved screening 
tools and strategies are required for detection and man-
agement of very low-density parasitaemia in the field [1, 
2].
The diagnostic methods currently used for mass 
screening with microscopy or on-site rapid diagnos-
tic tests (RDTs) are not sensitive enough to detect low-
density malarial infections [3]. The suitability of RDTs 
for surveillance of malaria in low transmission settings 
with low density and sub-microscopic infections is a 
concern. The use of polymerase chain reaction (PCR) 
for case detection could yield higher sensitivity to detect 
even a single parasite in a blood sample (approximately 
10 to 30  µl of blood volume) [4, 5]. However, PCR is 
expensive and requires thermocycling conditions, which 
is impracticable in the field setting, especially in coun-
tries with limited resources. Loop-mediated isothermal 
amplification (LAMP) theoretically enables the detection 
of low density and sub-microscopic infections with bet-
ter accuracy and greater ease [6–8]. In brief, LAMP is a 
molecular technique for nucleic acid amplification and 
performed to determine the presence of Plasmodium 
parasites in the blood samples based on the presence 
or absence of Plasmodium DNA. Primer sequences for 
LAMP amplification of the Plasmodium genus are for 
detection of Plasmodium falciparum, Plasmodium vivax, 
Plasmodium ovale and Plasmodium malariae.
Studies using LAMP for the detection of malaria in 
endemic areas are available. However, performance 
results reported in these studies are inconsistent. Until 
now, a comprehensive and systematic review of stud-
ies addressing the diagnostic accuracy of LAMP test in 
detection of human malaria is limited. The objective of 
the present study was to synthesize evidence on the diag-
nostic accuracy of LAMP test for the detection of malaria 
parasites among people living in endemic areas.
Methods
This study was performed, according to the Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
ysis for Diagnostic Test Accuracy (PRISMA-DTA) guide-
lines [9] (Additional file 1).
Search strategy
Electronic databases of Medline, EMBASE, Web of Sci-
ence, Cochrane systematic review database, the Latin 
American and Caribbean Health Sciences Literature 
(LILACS) and African Journals Online were searched for 
relevant studies published in English until May 2019 and 
an updated search in March 2020. The search was con-
ducted using keywords and Boolean operators: (“malaria” 
OR “plasmodium”) AND  (“LAMP” OR “loop-medi-
ated”  “dipsticks” OR “RDT” OR “rapid diagnosis” OR 
“rapid onsite diagnosis” OR “ICT” OR “immunochroma-
tographic”) OR (“microscopy” OR “PCR”). The references 
of retrieved articles and relevant reviews manually were 
checked for any additional studies.
Study selection
For selection of eligible studies, the criteria were set as 
described below.
Type of studies: Any study design, if it had evaluated 
the accuracy of LAMP in detection of malaria.
Participants: Participants living in the malaria endemic 
countries.
Index test: Any type of LAMP for diagnosis of malaria.
Comparator test: No comparator or an alternative diag-
nostic test (e.g. RDT/microscopy).
Future well-designed larger sample studies on LAMP assessment in passive and active malaria surveillances that use 
PCR as the reference standard and provide sufficient data to construct 2 × 2 diagnostic table are needed.
Keywords: Malaria, Diagnostic tests, Accuracy, Assays, Meta-analysis
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Target conditions: Detection of human malaria cases, 
regardless of parasite species.
Reference standard: PCR
Outcomes: The main outcome was measured in terms 
of sensitivity and the specificity of the diagnostic test of 
interest. Sensitivity refers to the probability that the index 
test result will be positive in an infected case. Specificity 
refers to the probability that the index test result will be 
negative in a non-infected case [10, 11].
To be eligible, a study must have provided sufficient 
data to construct 2 × 2 tables (true positive, false positive, 
false negative, true negative).
Exclusion criteria
Studies were excluded, if they used LAMP for detection 
of other settings or other disease apart from malaria (e.g. 
malaria in non-endemic areas, tuberculosis). Studies on 
special groups such as pregnant women or travellers were 
not included. Studies without sufficient data to construct 
2 × 2 tables were not considered.
Data extraction and management
One review author (DS) screened title and abstracts 
on the basis of the inclusion criteria. The same review 
author extracted information from all included studies. 
Data extracted were first author, publication year, coun-
try, setting, characteristic of study (sample size, details 
of tests used), characteristic study participants and out-
come data. Information collected were cross-checked by 
another review author (NHH). Any discrepancy between 
the two investigators was resolved by discussion and 
consensus.
Methodological quality assessment
To evaluate the methodological quality of included stud-
ies, the Quality Assessment of Diagnostic Accuracy 
Fig. 1 Study selection process
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Studies-2 (QUADAS-2) checklist was used. As described 
elsewhere [12], the QUADAS-2 checklist has four stand-
ard domains (‘patient selection’, ‘index tests’, ‘reference 
standards’ and ‘flow and timing’). The checklist con-
sists of signalling questions under each domain and the 
answers for these signalling questions allow the assess-
ment of the risk of bias for each domain.
Statistical heterogeneity between the studies was meas-
ured as I2 values, which describes the proportion of total 
variation in study estimates due to heterogeneity; I2 val-
ues > 50% is regarded as substantial heterogeneity [10, 
13]. The pooling of data was done only when there were 
two or more studies that used a particular type of LAMP 
that targeted the same species/genus.
As described elsewhere [11], sensitivity and specificity 
for each included study were described in the forest plots. 
A summary performance estimate was stratified by type 
of LAMP. Bivariate model for data analyses was used. 
Summary receiver operating characteristics (SROC) plots 
were created to display the results of individual stud-
ies in a receiver operating characteristics (ROC) space. 
This provides information on the overall performance 
of a test across different thresholds. The best diagnostic 
test is positioned in the top left hand corner of the ROC 
space, whereby both the sensitivity and specificity are 
close to 1.0 [10]. The area under the curve (AUC) shows 
the analytic summary of the diagnostic test performance 
among the included studies. An AUC of 0.97 or above 
demonstrates excellent accuracy [14]. Meta-regression 
analysis was performed to investigate the sources of het-
erogeneity among individual studies. Covariates such as 
sample size, study design, and the blinding of the index 
test and reference test results were used for the meta-
regression analysis. A p < 0.05 in the joint model was 
considered to contribute to heterogeneity. The potential 
publication bias was assessed by inspection of a funnel 
plot [15]. All statistical analyses were done with midas 
package in STATA 15.0 and RevMan 5.3 (The Nordic 
Cochrane Centre).
Results
Figure  1 illustrates the four-phase study selection pro-
cess. The initial search in the electronic databases yielded 
1075 citations. After removal of duplicates and by title 
and abstract screening, a total of 49 articles were eligi-
ble for full-text screening. Finally, 27 articles (9769 par-
ticipants) were selected for the current meta-analysis. 
The reasons of exclusion of 22 studies were summarized 
(Additional file 2).
Characteristics of the included studies
The characteristics of studies included in the current 
analysis are presented (Additional file  3). Of these 27 
studies, more than half of the studies included were 
cross-sectional design (54%, 14/27), while the remain-
ing 13 studies were case–control designs. A subset of 15 
Fig. 2 Geographical distribution of the included studies
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studies (19 data sets) assessed Pan LAMP [6, 8, 16–28], 
while 14 studies (17 data sets) used Plasmodium falcipa-
rum (Pf) LAMP [7, 8, 18, 20, 23, 25, 27–34] and only 6 
studies (6 data sets) used Plasmodium vivax (Pv) LAMP 
[27, 28, 32, 35–37].
Of these, two studies (7.4%) were multicountry stud-
ies that were carried out in India and Thailand [19] or 
Gambia, Papua New Guinea and Malaysia [20]. Of the 
remaining 25 single studies, the majority were done in 
the Asian region [7, 19, 20, 23, 25, 27, 29–32, 36–39], 
while ten studies in African countries [6, 8, 16–18, 21, 
22, 24, 33, 34], and three studies in the South American 
countries Brazil [28], Peru [26] and Venezuela [35]. Fig-
ure  2 shows the global distribution of the 27 included 
studies. The number of participants ranged widely from a 
minimum of 35 [8] to a maximum of 3008 [24]. The pub-
lication years covered from 2006 to 2019, and the major-
ity were published between 2015 and 2019 [6, 8, 20–28, 
33, 34, 37, 39].
Methodological quality of the included studies
The methodological quality of individual study is pro-
vided in Fig.  3. Many studies included in the current 
analysis were with high or unsure risk of bias. The sum-
mary of the methodological quality assessment across all 
studies are in Additional file 4. Less than half of the stud-
ies had either high risk of bias (48%) or low risk of bias 
(41%) in patient recruitments. The majority were with 
unclear risk of bias in the selection of index test (89%) 
or the reference standard (67%). There were low con-
cerns on the ‘applicability’ of the included studies with 
regard to patient selection (i.e. low concern because the 
included patients were matched the targeted population), 
index test (i.e. low concerns because the conducts or 
interpretation of LAMP is different from the designated 
procedures) and reference standard (i.e. low concerns 
because the reference standard PCR is useful for detec-
tion of malaria).
Test performances
Test performance of the studies that used Pan LAMP is 
provided in Additional file 5. Overall, the pooled sensitiv-
ity and specificity from 15 studies with 19 datasets that 
used Pan LAMP for detection of malaria were high at 
0.95 (95% CI 0.91 to 0.97) and 0.98 (95% CI 0.95 to 0.99), 
respectively (Fig. 4).
Overall, there were high pooled sensitivity from 14 
studies with 17 datasets (0.96, 95% CI 0.94 to 0.98) and 
specificity (0.99, 95% CI 0.96 to 1.00) for the Pf LAMP 
(Fig. 5). The Pv LAMP from 6 studies showed (sensitiv-
ity: 0.96, 95% CI 0.91 to 0.99) and 0.99 (specificity: 95% 
CI 0.56 to 1.00) (Additional file 6). An SROC model for 
the Pan LAMP is shown in Fig.  6. The AUCs for Pan 
LAMP (0.99, 95% CI 0.98–1.00), the Pf LAMP (0.99, 95% 
CI 0.96–1.0) and the Pv LAMP was (1.0 95% CI 0.98–1.0) 
indicated that the diagnostic performance of these tests 
were within the excellent accuracy range (Additional files 
7 and 8).
There was substantial between-study heterogene-
ity as the I2 values for sensitivity and specificity of all 
LAMP tested were 94.86% and 95.71%, respectively 
(Figs.  4, 5). To investigate the source of heterogeneity, 
Fig. 3 Methodological quality assessment of each individual study
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meta-regression analysis was performed with four covar-
iates such as sample size, blinding for index test, blind-
ing for reference test and the study design. The results of 
meta-regression are presented in Table 1. Of these poten-
tial confounding factors, sample size had the greatest 
impact on the sensitivity and specificity of Pan LAMP.
Discussion
The present review included 27 studies (9769 partici-
pants) across 17 malaria endemic countries in the Afri-
can and South-East Asia regions. The major observations 
are as follows:
1. The pooled sensitivities and specificities of the Pan 
LAMP, the Pf LAMP and the Pv LAMP were high in 
terms of reference test PCR.
2. Species-specific LAMP tests (Pf LAMP, Pv LAMP) 
had higher levels of sensitivities and specificities 
than that of the genus-specific LAMP test (i.e. Pan 
LAMP).
The vast majority of the primary studies in the pre-
sent analysis (92%) was conducted in the African and 
South-East Asia regions that reported ≈ 97% of the total 
malaria cases globally in the year 2016 [2]. This implied 
that the findings of primary studies represented the 
endemic areas targeted for malaria control/elimination. 
The current findings of sensitivities were comparable 
with a published meta-analysis, which compared the 
accuracy of LAMP with PCR [40]. However, the earlier 
meta-analysis showed a specificity of 91% [40], which 
was lower than the current findings. This variation might 
be due to the differences in the number of primary stud-
ies in these meta-analysis studies. The earlier analysis 
included only four primary studies, while the current 
analysis consisted of 27 studies. The current findings of 
high sensitivity of LAMP suggested that it would be a 
suitable test to ‘rule-out’ malaria, when the test shows a 
negative result. Moreover, the nearly perfect specificity 
of LAMP for detection of malaria suggests that this test 
would be a suitable test to ‘rule-in’ the disease, when it 
shows a positive result.
Fig. 4 Forest plot of sensitivity and specificity for Pan LAMP
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On stratification, the pooled sensitivities and specifici-
ties of species-specific LAMP tests (Pf LAMP, Pv LAMP) 
were higher than the genus-specific LAMP test (Pan 
LAMP). Pan LAMP is for initial screening of malaria, 
irrespective of speciation. This would help save costs 
through a prevention from over-treatment for malaria 
which is important in malaria endemic areas with limited 
resources.
Regarding the methodology, heterogeneity is 
expected to be substantial in diagnostic test accuracy 
(DTA) studies. Therefore, the models used in DTA 
reviews are by default random effects models [10] and 
this guidance was followed. Bivariate model, which rec-
ommended purely binary tests or when different stud-
ies reported similar thresholds was chosen [11]. The 
current report focused on sensitivity and specificity, 
rather than other accuracy measures. This is because 
any other measure would be calculated on the basis of 
these two main parameters.
Study limitations
Due to small number of studies included in species-spe-
cific LAMPs, a low power to obtain the true accuracies 
was a concern. This concern was supported by a meta-
regression analysis, showing that sample size in pri-
mary studies had an impact on the test performances of 
LAMPs. The majority of the included studies had unclear 
risk of bias because it was not clear whether the index 
test was interpreted without the knowledge of the results 
Fig. 5 Forest plot of sensitivity and specificity for Pf LAMP
Fig. 6 SROC plot of studies that used Pan LAMP
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of the reference standard. Hence, there might be possi-
bilities of over/under estimations of the test accuracies.
There are confounding factors that could have effects 
on the pooled sensitivities and specificities of the LAMP 
tests. For instance, a variation in types of PCR used in the 
primary studies (i.e. nested PCR (nPCR), multiplex PCR, 
real-time quantitative PCR (qPCR), reverse transcription 
PCR) might have different diagnostic accuracy in detec-
tion of malaria. It has been reported that nPCR had a 
lower specificity than qPCR for the diagnosis of malaria 
[40].
Immunity level of travellers from non-endemic coun-
tries is relatively low compared to the residences in 
endemic areas [41]. Immunity levels of pregnant mothers 
is also relatively lower than the non-pregnant participants 
probably due to physiological changes in pregnancy [42]. 
The current review did not include studies with travellers 
or pregnant women. Hence, the estimates resulted in our 
review were less likely of bias related to immune status.
Nevertheless, there are several features of LAMPs that 
make it a potential tool for field use in malaria control/
elimination programmes; it has (i) a high specificity, 
which reduce the frequency of false-positive results [19], 
(ii) a high sensitivity, which could translate into a screen-
ing test with high PPV and NPV in areas of low malaria 
prevalence where attempts are being made to eliminate 
this disease [8], (iii) demonstrated efficacy in detect-
ing and identifying even P. vivax infections, which often 
predominate in countries entering malaria elimina-
tion in Southeast Asia and Latin America [27, 35], (iv) 
majority of the LAMP assays described are less resource 
intensive than standard PCR tests [6, 7], and (v) it can be 
performed by technicians after appropriate training in a 
rural health clinic or field site [6].
Conclusions
The current findings suggest that LAMP-based assays 
are appropriate for detecting low-level malaria parasite 
infections in the field and would become valuable tools 
for malaria control and elimination programmes. Future 
well-designed larger sample studies on LAMP assessment 
in passive and active malaria surveillances that use PCR 
as the reference standard and provide sufficient data to 
construct 2 × 2 diagnostic table are needed.
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